Tabula Rasa HealthCare, Inc.

NasdaqGM:TRHC Stok Raporu

Piyasa değeri: US$284.0m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Tabula Rasa HealthCare Yönetim

Yönetim kriter kontrolleri 3/4

Tabula Rasa HealthCare's CEO is Brian Adams, appointed in Sep 2022, has a tenure of 1.17 years. total yearly compensation is $2.30M, comprised of 19.6% salary and 80.4% bonuses, including company stock and options. directly owns 1.55% of the company’s shares, worth $4.40M. The average tenure of the management team and the board of directors is 2.5 years and 5 years respectively.

Anahtar bilgiler

Brian Adams

İcra Kurulu Başkanı

US$2.3m

Toplam tazminat

CEO maaş yüzdesi19.6%
CEO görev süresi1.2yrs
CEO sahipliği1.5%
Yönetim ortalama görev süresi2.5yrs
Yönetim Kurulu ortalama görev süresi5yrs

Son yönetim güncellemeleri

Recent updates

Continuing To Avoid Tabula Rasa HealthCare Inc.

May 19

Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?

May 11
Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?

Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

Feb 09
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)

Jan 19
Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)

Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching

Dec 06
Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching

Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?

Nov 05
Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?

Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price

Jul 26
Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price

Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

Jun 28
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed

Jun 05
We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed

Tabula Rasa HealthCare, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 07

Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price

Apr 02
Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price

Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt

Mar 12
Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt

Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years

Feb 19
Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years

CEO Tazminat Analizi

Brian Adams'un ücretlendirmesi Tabula Rasa HealthCare'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$64m

Dec 31 2022US$2mUS$450k

-US$77m

Sep 30 2022n/an/a

-US$72m

Jun 30 2022n/an/a

-US$58m

Mar 31 2022n/an/a

-US$59m

Dec 31 2021US$2mUS$403k

-US$52m

Sep 30 2021n/an/a

-US$70m

Jun 30 2021n/an/a

-US$80m

Mar 31 2021n/an/a

-US$80m

Dec 31 2020US$2mUS$385k

-US$57m

Sep 30 2020n/an/a

-US$57m

Jun 30 2020n/an/a

-US$44m

Mar 31 2020n/an/a

-US$36m

Dec 31 2019US$3mUS$408k

-US$32m

Sep 30 2019n/an/a

-US$36m

Jun 30 2019n/an/a

-US$18m

Mar 31 2019n/an/a

-US$40m

Dec 31 2018US$2mUS$408k

-US$47m

Sep 30 2018n/an/a

-US$26m

Jun 30 2018n/an/a

-US$30m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$882kUS$328k

US$13m

Sep 30 2017n/an/a

-US$3m

Jun 30 2017n/an/a

-US$8m

Mar 31 2017n/an/a

-US$7m

Dec 31 2016US$2mUS$278k

-US$3m

Tazminat ve Piyasa: Brian's total compensation ($USD2.30M) is above average for companies of similar size in the US market ($USD1.53M).

Tazminat ve Kazançlar: Brian's compensation has been consistent with company performance over the past year.


CEO

Brian Adams (41 yo)

1.2yrs

Görev süresi

US$2,301,712

Tazminat

Mr. Brian W. Adams serves as President at Tabula Rasa HealthCare, Inc since September 14, 2022. He served as Vice President of Finance at CareKinesis, Inc. since October 2011 until 2014. He had been Co-Pre...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Brian Adams
CEO, President & Director1.2yrsUS$2.30m1.55%
$ 4.4m
Thomas Cancro
Chief Financial Officer1.8yrsUS$1.46m0.41%
$ 1.2m
Michael Greenhalgh
COO & President of Pharmacy Services9.4yrsUS$1.86m1.2%
$ 3.4m
Michael Bruno
VP, Corporate Controller & Chief Accounting Officerless than a yearVeri yok0.037%
$ 105.0k
Bob Sullivan
Chief Technology Officer3.3yrsVeri yokVeri yok
Phillip Heath
Chief Administrative Officer8.8yrsVeri yokVeri yok
Frank Sparacino
Senior Vice President of Investor Relations & Corporate Development3.7yrsVeri yokVeri yok
Richard Rew
Chief Legal Officer & Corporate Secretaryless than a yearVeri yokVeri yok
Kathleen Larkin
Chief People Officer1.8yrsVeri yokVeri yok
Andrea Speers
Chief of Staffless than a yearVeri yokVeri yok
Kim Browning
Chief of Staff5.5yrsVeri yokVeri yok
Alan Stein
Senior Vice President of Healthcare Analytics5.5yrsVeri yokVeri yok

2.5yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: TRHC's management team is considered experienced (2.5 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Brian Adams
CEO, President & Directorless than a yearUS$2.30m1.55%
$ 4.4m
Jonathan Schwartz
Independent Director1.2yrsUS$257.50k0.29%
$ 823.1k
Dennis Helling
Independent Director6.7yrsUS$235.53k0.41%
$ 1.2m
Alan Sadowsky
Member of Strategic Advisory Boardno dataVeri yokVeri yok
Lawrence Lesko
Member of Strategic Advisory Boardno dataVeri yokVeri yok
Jocelyn Konrad
Member of Strategic Advisory Boardno dataVeri yokVeri yok
Michael Purcell
Independent Board Chairman5.3yrsUS$257.78k0.52%
$ 1.5m
Samira Beckwith
Independent Director6.3yrsUS$239.47k0.33%
$ 927.1k
Pamela Schweitzer
Independent Director4.7yrsUS$229.67k0.33%
$ 934.6k
Kathrine O'Brien
Independent Director5yrsUS$231.33k0.17%
$ 488.5k
Brian Isetts
Member of Strategic Advisory Boardno dataVeri yokVeri yok
Margaret Johnson
Member of Strategic Advisory Boardno dataVeri yokVeri yok

5.0yrs

Ortalama Görev Süresi

62.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TRHC's board of directors are considered experienced (5 years average tenure).